Home

Janus Henderson Group reported a 4% stake in Entrada Therapeutics TRDA · 1,521,281 sh · amendment · passive holder

Trade details

Type
5% stake report
Report
13G passive · amendment
Stake
4%
Last report
5.6% · filed 25/05/14
Shares held
1,521,281 sh
Class
Common Stock
Event date
25/06/30
Filed
25/08/14

4% stake · below 5%

Stake
4%
Last report
5.6%
Since last report
−1.6pp

Entrada Therapeutics trades, last 26 weeks

What else happened in Entrada Therapeutics around then

Filed or reported within 30 days of the trade day · 25/05/31~25/07/30

Janus Henderson Group's other 5% stake reports

  • Janus Henderson Group

    5% stakeEyePoint

    10.9% stake

    Filed 09/08

  • Janus Henderson Group

    5% stakeVogenx

    13% stake

    Filed 09/08

  • Janus Henderson Group

    5% stakeMirum Pharmaceuticals

    9.7% stake

    Filed 08/13

  • Janus Henderson Group

    5% stakeAssembly Biosciences

    6.9% stake

    Filed 08/13

  • Janus Henderson Group

    5% stakeTarsus Pharmaceuticals

    6.5% stake

    Filed 08/13